doxorubicin accord healthcare 2 mg/ml sol. perf. (à diluer) i.v. flac.
accord healthcare b.v. - chlorhydrate de doxorubicine 10 mg/5 ml - solution à diluer pour perfusion - 2 mg/ml - chlorhydrate de doxorubicine 2 mg/ml - doxorubicin
doxorubicin accord healthcare 2 mg/ml sol. perf. (à diluer) i.v. flac.
accord healthcare b.v. - chlorhydrate de doxorubicine 10 mg/5 ml - solution à diluer pour perfusion - 2 mg/ml - chlorhydrate de doxorubicine 2 mg/ml - doxorubicin
doxorubicin accord healthcare 2 mg/ml sol. perf. (à diluer) i.v. flac.
accord healthcare b.v. - chlorhydrate de doxorubicine 10 mg/5 ml - solution à diluer pour perfusion - 2 mg/ml - chlorhydrate de doxorubicine 2 mg/ml - doxorubicin
doxorubicin accord healthcare 2 mg/ml sol. perf. (à diluer) i.v. flac.
accord healthcare b.v. - chlorhydrate de doxorubicine 10 mg/5 ml - solution à diluer pour perfusion - 2 mg/ml - chlorhydrate de doxorubicine 50 mg/ml - doxorubicin
zolsketil pegylated liposomal
accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.
doxorubicin hydrochloride injection solution
omega laboratories limited - chlorhydrate de doxorubicine - solution - 2mg - chlorhydrate de doxorubicine 2mg - antineoplastic agents
doxorubicine g gam 10 mg/5 ml, solution injectable pour perfusion
sandoz - chlorhydrate de doxorubicine - solution - 10 mg - composition pour 5 ml de solution injectable > chlorhydrate de doxorubicine : 10 mg - antibiotiques cytotoxiques et apparentes
doxorubicine g gam 2 mg/ml, solution injectable pour perfusion
sandoz - chlorhydrate de doxorubicine - solution - 50 mg - composition pour 25 ml de solution injectable > chlorhydrate de doxorubicine : 50 mg - antibiotiques cytotoxiques et apparentes
doxorubicine medipha sante 2 mg/ml, solution pour perfusion
medipha sante - chlorhydrate de doxorubicine - solution - 2 mg - composition pour 1 ml de solution pour perfusion > chlorhydrate de doxorubicine : 2 mg - antibiotiques cytotoxiques et apparentes
doxorubicine winthrop 2 mg/ml, solution pour perfusion
sanofi aventis france - chlorhydrate de doxorubicine - solution - 2 mg - composition pour 1 ml de solution pour perfusion > chlorhydrate de doxorubicine : 2 mg - antibiotiques cytotoxiques et apparentes